Cover Image
QR Code

Exploring the Evolving Treatment Paradigm in the Management of Inflammatory Bowel Disease.

It is an extraordinarily exciting time for clinicians who manage patients with inflammatory bowel disease. There are a number of newer treatment options which can help many patients with moderate-to-severe disease into remission and maintain that remission for extended periods. Many more options wil...

Full description

Published in:Journal of Managed Care Medicine Vol. 23; no. 1; pp. 32 - 38
Main Author: Farraye, Francis A.
Format: algorithm CEU pictorial review tables/charts Journal Article
Published: National Association of Managed Care Physicians, Inc. 2020
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143062032&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 143062032
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10941525
        9084
      jtl: Journal of Managed Care Medicine
      issn: 10941525
      maglogo: N
    pubinfo:
      dt: 2020
      vid: 23
      iid: 1
      pid: 54351
      pub: National Association of Managed Care Physicians, Inc.
      place: Glen Allen, Virginia
    artinfo:
      ui:
        143062032
        143062032
        143062032
        143062032
      ppf: 32
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Exploring the Evolving Treatment Paradigm in the Management of Inflammatory Bowel Disease.
      aug:
        au: Farraye, Francis A.
        affil: Senior Associate Clinician and Director of the Inflammatory Bowel Disease Center at the Mayo Clinic in Jacksonville, FL
      sug:
        subj:
          Inflammatory Bowel Diseases Drug Therapy
          Disease Management
          Decision Making, Clinical
          Inflammatory Bowel Diseases Risk Factors
          Education, Continuing (Credit)
          Disease Remission
          Risk Assessment
          Biological Products Therapeutic Use
          Gastrointestinal Diseases Prevention and Control
      ab: It is an extraordinarily exciting time for clinicians who manage patients with inflammatory bowel disease. There are a number of newer treatment options which can help many patients with moderate-to-severe disease into remission and maintain that remission for extended periods. Many more options will be coming to the market in the next few years.
      pubtype: Academic Journal
      doctype:
        algorithm
        CEU
        pictorial
        review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N